KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Inventory (2016 - 2025)

Charles River Laboratories International has reported Inventory over the past 17 years, most recently at $299.1 million for Q4 2025.

  • Quarterly results put Inventory at $299.1 million for Q4 2025, up 7.38% from a year ago — trailing twelve months through Dec 2025 was $299.1 million (up 7.38% YoY), and the annual figure for FY2025 was $299.1 million, up 7.38%.
  • Inventory for Q4 2025 was $299.1 million at Charles River Laboratories International, down from $302.6 million in the prior quarter.
  • Over the last five years, Inventory for CRL hit a ceiling of $380.3 million in Q4 2023 and a floor of $181.7 million in Q3 2021.
  • Median Inventory over the past 5 years was $279.0 million (2024), compared with a mean of $274.1 million.
  • Biggest five-year swings in Inventory: surged 48.65% in 2023 and later fell 26.75% in 2024.
  • Charles River Laboratories International's Inventory stood at $199.1 million in 2021, then increased by 28.45% to $255.8 million in 2022, then skyrocketed by 48.65% to $380.3 million in 2023, then decreased by 26.75% to $278.5 million in 2024, then rose by 7.38% to $299.1 million in 2025.
  • The last three reported values for Inventory were $299.1 million (Q4 2025), $302.6 million (Q3 2025), and $279.6 million (Q2 2025) per Business Quant data.